adorable baby smiling with joy

Peds Calc

Safety Information

Clonidine Contraindications & InteractionsWhen Not to Use & Important Drug Interactions

Assess cardiovascular status, mental-health history, and concurrent medications before starting clonidine; beta-agonist reversal of hypotension can be difficult once toxicity occurs.

Back to Clonidine Overview

Absolute contraindications include prior anaphylaxis to clonidine or adhesive components of the transdermal system, and use in neonates with significant sinus node dysfunction. Relative contraindications cover bradyarrhythmias, hypotension, severe coronary artery disease, depressive disorders, and advanced renal insufficiency where drug clearance is prolonged.

Contraindications

Absolute Contraindications (Never Use)

Known hypersensitivity to clonidine or formulation excipients

Known hypersensitivity to clonidine or formulation excipients

Use of clonidine transdermal system in patients with adhesive sensitivity or contact dermatitis

Use of clonidine transdermal system in patients with adhesive sensitivity or contact dermatitis

Relative Contraindications (Use With Caution)

Sinus node dysfunction, AV block, or bradyarrhythmias without a pacemaker

Sinus node dysfunction, AV block, or bradyarrhythmias without a pacemaker

Symptomatic hypotension or autonomic dysfunction—risk of profound blood pressure drops

Symptomatic hypotension or autonomic dysfunction—risk of profound blood pressure drops

Major depressive disorder or history of suicidal ideation—monitor mood closely

Major depressive disorder or history of suicidal ideation—monitor mood closely

Renal impairment (creatinine clearance <30 mL/min) or hepatic impairment—titrate slowly and monitor for accumulation

Renal impairment (creatinine clearance <30 mL/min) or hepatic impairment—titrate slowly and monitor for accumulation

Concomitant CNS depressants, antihypertensives, or beta-blockers—additive sedation and hypotension

Concomitant CNS depressants, antihypertensives, or beta-blockers—additive sedation and hypotension

Abrupt withdrawal risk—ensure caregivers understand tapering requirements

Abrupt withdrawal risk—ensure caregivers understand tapering requirements

Clinical References

Kapvay (clonidine hydrochloride) Extended-Release Tablets LabelU.S. Food and Drug Administration (2010)Label
Medications for Opioid Use Disorder in AdolescentsSubstance Abuse and Mental Health Services Administration (2020)Guidance